BULERIA. Repositorio Institucional de la Universidad de León
Publication
Artículo científico (JournalArticle)
Effect of dietary phenolic compounds intake on mortality in the “Seguimiento Universidad De Navarra” (SUN) Mediterranean cohort
[EN] Plant-based dietary patterns have been demonstrated to reduce the risk of non-communicable disease (NCD), including cardiovascular disease (CVD), type 2 diabetes, cancer, and all-cause mortality. Phenolic compounds (PC), abundant in plant-based foods, have been considered as instrumental in this attenuation of NCD risk. We evaluated the association between dietary intake of PC and the risk of all-cause mortality in a relatively young Mediterranean cohort of 18,173 Spanish participants in the “Seguimiento Universidad de Navarra” (SUN) project, after a median follow-up of 12.7 years. Intake of PC was estimated at baseline and repeatedly after 10-year follow-up using a 136-item validated food frequency questionnaire and the Phenol-Explorer database. During 236,329 person-years, 544 deaths were confirmed. Cox regression models compared low intake (lowest quintile) vs. high intake (the four upper quintiles merged, as a reference category) of total energy-adjusted PC intake. Adjusted hazard ratios (HR) for low PC intake among those participants aged over 45 years during follow-up were 1.32; 95% CI 1.02–1.71 for all-cause mortality, HR:1.44; 95% CI 1.02–2.02 for cancer mortality; HR: 0.88; 95% CI 0.47–1.66 for CVD mortality and HR: 1.69 95% CI 1.04–2.74 for causes of death other than cancer or CVD. In conclusion, a low intake of total PC was associated with a significantly higher risk of all-cause mortality, and, specifically, a higher risk for cancer in a relatively young cohort. Among PC classes a low intake of flavonoids and phenolic acids showed significant effects for non-cancer/non-CVD mortality. Cherries, chocolate, apples and pears, olives, and coffee, were the major sources of between-person variability for total PC intake in our Mediterranean cohort, SI, Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The project SUN has received funding from the Spanish Government - Instituto de Salud Carlos III, and the European Regional Develop- ment Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, PI20/00564 and G03/140), the Government of Navarra (27/2011, 45/2011, 122/2014), the National Plan on Drugs (2020 / 021) as well as the University of Navarra
Project:
MSC / Acción Estratégica de Salud RD 06
,
MINECO / Acción Estratégica de Salud CIBER-OBN
,
MINECO / Programa Estatal de I+D+I Orientada a los Retos de la Sociedad PI13
,
MINECO / Programa Estatal de I+D+I Orientada a los Retos de la Sociedad PI14
,
MINECO / Programa Estatal de I+D+I Orientada a los Retos de la Sociedad PI14
,
MINECO / Programa Estatal de I+D+I Orientada a los Retos de la Sociedad PI14
,
ISCIII / Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia PI17
,
ISCIII / Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I PI20
DOI: https://link.springer.com/article/10.1007/s00394-025-03581-5, https://hdl.handle.net/10612/28012
HANDLE: https://link.springer.com/article/10.1007/s00394-025-03581-5, https://hdl.handle.net/10612/28012